Product Details for ANDA 060359
ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE)
EQ 250MG BASE
Marketing Status: Prescription
EQ 125MG BASE
Marketing Status: Discontinued
EQ 500MG BASE
Marketing Status: Discontinued
EQ 250MG BASE
Marketing Status: Prescription
Active Ingredient: ERYTHROMYCIN STEARATE
Proprietary Name: ERYTHROCIN STEARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 250MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code:
Application Number: A060359
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE)
Proprietary Name: ERYTHROCIN STEARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 250MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code:
Application Number: A060359
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 125MG BASE
Marketing Status: Discontinued
Active Ingredient: ERYTHROMYCIN STEARATE
Proprietary Name: ERYTHROCIN STEARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 125MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060359
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE)
Proprietary Name: ERYTHROCIN STEARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 125MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060359
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 500MG BASE
Marketing Status: Discontinued
Active Ingredient: ERYTHROMYCIN STEARATE
Proprietary Name: ERYTHROCIN STEARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 500MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060359
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ERYTHROCIN STEARATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 500MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A060359
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information